Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment,United European Gastroenterology Journal

当前位置： X-MOL 学术 › United Eur. Gastroenterol. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment
United European Gastroenterology Journal ( IF 6 ) Pub Date : 2024-04-09 , DOI: 10.1002/ueg2.12547
Bénédicte Caron _{1,

2,

3,

4} , Alexandre Habert ₁ , Olivier Bonsack ₁ , Houda Camara ₅ , Elodie Jeanbert ₅ , Tommaso Lorenzo Parigi _{6,

7} , Patrick Netter ₈ , Silvio Danese _{6,

7} , Laurent Peyrin‐Biroulet _{1,

2,

3,

4,

9}

Affiliation

Many patients with inflammatory bowel disease (IBD) have signs or symptoms of active disease despite multiple treatment attempts. This emerging concept is defined as difficult-to-treat IBD.

中文翻译：